Motley FoolNOV 13 min read$OSPN

OneSpan (OSPN) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, Oct. 30, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...

Original reporting

Motley Fool · Motley Fool Transcribing, https://www.facebook.com/themotleyfool/

Published Nov 1, 2025, 10:21 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 1, 2025, 11:30 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

OneSpan (OSPN) Q3 2025 Earnings Call Transcript — source image — Source · www.fool.com

Decision brief

The 30-second read

$OSPNBullishMed

Why it matters

The earnings call reinforces investor confidence, potentially leading to short-term stock appreciation.

Market read

The earnings call is highly relevant for traders focusing on tech and cybersecurity stocks, especially those with exposure to OSPN.

What to watch

Potential macroeconomic headwinds or sector-specific regulatory changes could negatively impact stock performance despite positive earnings.

Relevance 6/10Timing: High; earnings calls are timely events impacting short-term trading decisions.

Background

OneSpan reported its Q3 2025 financial results, highlighting revenue stability and ongoing product innovation.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$OSPNBullishMedium confidence

Context

The earnings call transcript provides insights into OneSpan's financial performance and strategic direction.

Expected impact

Expected slight increase in stock price over the short term (1-3%)

Evidence & confidence

The company's earnings beat analyst expectations, and management's guidance remains optimistic, though macroeconomic uncertainties could temper gains.

Market effects

Sector

Positive sentiment may bolster the cybersecurity and enterprise software sectors.

Regional

Primarily affects U.S. markets; limited global impact.

Global

Moderate; reflects sector-specific performance rather than macroeconomic shifts.

Counterpoint

What could challenge this read

Some analysts may interpret the stable earnings as a sign of limited growth potential, advising caution against overexposure.

Key entities

Company
OneSpan Inc.
A provider of digital identity and anti-fraud solutions.
Media Outlet
Motley Fool
Financial news and analysis platform.

Read at source ← All news

SEP 9

$OSPNMed

OneSpan’s (OSPN) Subscription Growth Masks A Shrinking Bottom Line

OneSpan (OSPN) reported Q2 2026 revenue of $60.5M, up 1% YoY. Subscription revenue grew 11% to $46.7M, while operating income fell 17% to $8.7M. The company raised full-year guidance, expecting $248M-$252M in revenue and $67M-$71M in Adjusted EBITDA. Net income declined to $6.8M, or $0.18 per share, from $8.3M a year earlier.

yahoo.com2 min

AUG 12

$OSPNMedAI 8/10

OneSpan (OSPN) Q2 2026 Earnings Call Transcript

OneSpan (OSPN) reported Q2 2026 revenue of $60.5 million, up 1% year over year, with subscription revenue at $46.7 million (+11%) and ARR of $189.7 million (+7%). Adjusted EBITDA was $16.9 million (28% margin). Full-year guidance raised to revenue $248-$252 million and adjusted EBITDA $67-$71 million. The company also launched DigipassONE and returned $2.9 million via repurchases.

fool.com6 min

AUG 4

$OSPNMed

OneSpan Reports Second Quarter 2026 Financial Results

OneSpan Inc. (OSPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OneSpan Reports Second Quarter 2026 Financial Results • Revenue increased 1% year-over-year to $60.5 million • Subscription revenue increased 11% year-over-year to $46.7 million • Operating income decreased 17% year-over-year to $8.7 million • Adjusted EBITDA decreas

SEC EDGAR 8-K7 min

OCT 25

$METAMed

Meta’s AI commitments surge to US$825 billion, testing financing power

Meta Platforms' AI infrastructure spending is causing financial strain. Free cash flow turned negative in Q3 2026, and future commitments reached $825 billion. This reflects rising pressure on the company's financing power, according to Bloomberg.

digitimes.com2 min

OCT 24

$CLYMHighAI 8/10

Climb Bio reports early data on budoprutug for kidney diseases

Climb Bio (CLYM) presented Phase 2 trial data for budoprutug, an anti-CD19 antibody, showing B-cell depletion and PLA2R antibody reductions in kidney disease patients. The 200 mg dose achieved 70% mean antibody reduction, with 5/13 patients in remission. The 600 mg dose showed deeper B-cell depletion. The drug was well-tolerated. Climb Bio expects more data in 2027. Primary membranous nephropathy affects 75,000 people in the U.S. without FDA-approved treatments.

investing.com2 min